@biden_worldnewsSo India is putting a cap on trade margins for cancer drugs, and the projected effect is a 70% drop in price. The point of the whole thing is to shut down excessive mark-ups that pile onto what patients pay. For the priciest medicines people there rely on, the goal is affordability, not luxury pricing. Sure.
View original post


















